{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T23:02:48Z","timestamp":1773356568671,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Sister Institution Network Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4079-1","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T08:35:36Z","timestamp":1517906136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Germline BRCA1\/BRCA2 mutations among high risk breast cancer patients in Jordan"],"prefix":"10.1186","volume":"18","author":[{"given":"Hikmat","family":"Abdel-Razeq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Al-Omari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Zahran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Arun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"key":"4079_CR1","unstructured":"Cancer incidence in Jordan 2013. Jordan cancer registry. Non-Communicable Diseases Directorate Ministry of Health, Jordan Available at \n                    http:\/\/www.moh.gov.jo\/Echobusv3.0\/SystemAssets\/7c73e811-df26-411d-8ed4-de050373aea0.pdf\n                    \n                   Accessed 18 Dec 2016."},{"key":"4079_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ijsu.2006.06.015","volume":"5","author":"NS El Saghir","year":"2007","unstructured":"El Saghir NS, Khalil MK, Eid T, El Kinge AR, Charafeddine M, Geara F, et al. Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. Int J Surg. 2007;5:225\u201333.","journal-title":"Int J Surg"},{"key":"4079_CR3","doi-asserted-by":"publisher","first-page":"e417","DOI":"10.1016\/S1470-2045(13)70165-7","volume":"14","author":"L Chouchane","year":"2013","unstructured":"Chouchane L, Boussen H, Sastry KS. Breast cancer in Arab populations: molecular characteristics and disease management implications. Lancet Oncol. 2013;14:e417\u201324.","journal-title":"Lancet Oncol"},{"key":"4079_CR4","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s10552-016-0775-9","volume":"27","author":"FA Gonzales","year":"2016","unstructured":"Gonzales FA, Taplin SH, Yu M, Breen N, Cronin KA. Receipt of mammography recommendations among white and non-white women before and after the 2009 United States preventive services task force recommendation change. Cancer Causes Control. 2016;27:977\u201387.","journal-title":"Cancer Causes Control"},{"key":"4079_CR5","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1002\/cncr.28105","volume":"119","author":"LE Pace","year":"2013","unstructured":"Pace LE, He Y, Keating NL. Trends in mammography screening rates after publication of the 2009 US preventive services task force recommendations. Cancer. 2013;119:2518\u201323.","journal-title":"Cancer"},{"key":"4079_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ypmed.2014.10.024","volume":"69","author":"LJ Finney Rutten","year":"2014","unstructured":"Finney Rutten LJ, Ebbert JO, Jacobson DJ, Squiers LB, Fan C, Breitkopf CR, et al. Changes in U.S. preventive services task force recommendations: effect on mammography screening in Olmsted County, MN 2004-2013. Prev Med. 2014 Dec;69:235\u20138.","journal-title":"Prev Med"},{"key":"4079_CR7","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1056\/NEJMra0802968","volume":"359","author":"WD Foulkes","year":"2008","unstructured":"Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med. 2008;359:2143\u201353.","journal-title":"N Engl J Med"},{"key":"4079_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","volume":"91","author":"J Peto","year":"1999","unstructured":"Peto J, Collins N, Batfoot R, Seal S, Warren W, Rahman N, et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early onset breast cancer. J Natl Cancer Inst. 1999;91:943\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"4079_CR9","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25:1329\u201333.","journal-title":"J Clin Oncol"},{"key":"4079_CR10","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst. 2013;105:812\u201322.","journal-title":"J Natl Cancer Inst"},{"key":"4079_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/928562","volume":"2013","author":"F Karami","year":"2013","unstructured":"Karami F, Mehdipour P. A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer. Biomed Res Int. 2013;2013:1\u201321.","journal-title":"Biomed Res Int"},{"key":"4079_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1634\/theoncologist.2014-0364","volume":"20","author":"NS El Saghir","year":"2015","unstructured":"El Saghir NS, Zgheib NK, Assi HA, Khoury KE, Bidet Y, Jaber SM, et al. BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer. Oncologist. 2015;20:357\u201364.","journal-title":"Oncologist"},{"key":"4079_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1897-4287-10-7","volume":"10","author":"N Jalkh","year":"2012","unstructured":"Jalkh N, Nassar-Slaba J, Chouery E, Salem N, Uhrchammer N, Golmard L, et al. Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon. Hered Cancer Clin Pract. 2012;10:7.","journal-title":"Hered Cancer Clin Pract"},{"key":"4079_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.7150\/ijms.5014","volume":"10","author":"A Laraqui","year":"2013","unstructured":"Laraqui A, Uhrhammer N, Lahlou-Amine I, EL Rhaffouli H, El Baghdadi J, Dehayni M, et al. Mutation screening of the BRCA1 gene in early onset and familial breast\/ovarian cancer in Moroccan population. Int J Med Sci. 2013;10:60\u20137.","journal-title":"Int J Med Sci"},{"key":"4079_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1756-9966-29-82","volume":"29","author":"SS Ibrahim","year":"2010","unstructured":"Ibrahim SS, Hafez EE, Hashishe MM. Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection. J Exp Clin Cancer Res. 2010;29:82\u201391.","journal-title":"J Exp Clin Cancer Res"},{"key":"4079_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10549-006-9303-z","volume":"102","author":"KD Awadelkarim","year":"2007","unstructured":"Awadelkarim KD, AcetoG VS, Elhaj A, Morgano A, Mohamedani AA, et al. BRCA1 and BRCA2 status in a central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors. Breast Cancer Res Treat. 2007;102:189\u201399.","journal-title":"Breast Cancer Res Treat"},{"key":"4079_CR17","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.7314\/APJCP.2013.14.10.5671","volume":"14","author":"TN Hasan","year":"2013","unstructured":"Hasan TN, Shafi G, Syed NA, Alsaif MA, Alsaif AA, Alshatwi AA. Lack of association of BRCA1 and BRCA2 variants with breast cancer in an ethnic population of Saudi Arabia, an emerging high-risk area. Asian Pac J Cancer Prev. 2013;14:5671\u20134.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4079_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3233\/CBM-2008-4102","volume":"4","author":"W Troudi","year":"2008","unstructured":"Troudi W, Uhrhammer N, Romdhane KB, Sibille C, Amor MB, El Khil HK, et al. Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer. Cancer Biomark. 2008;4:11\u20138.","journal-title":"Cancer Biomark"},{"key":"4079_CR19","unstructured":"NCCN Clinical Practice Guidelines in Oncology, Genetic\/Familial High-Risk Assessment: Breast and Ovarian. Version 2.2017. \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf\n                    \n                   Accessed 18 Dec. 2016."},{"key":"4079_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/humu.1380020402","volume":"2","author":"AL Beaudet","year":"1993","unstructured":"Beaudet AL, Tsui LC. A suggested nomenclature for designating mutations. Hum Mutat. 1993;2:245\u20138.","journal-title":"Hum Mutat"},{"key":"4079_CR21","unstructured":"PopulationPyramid.net available at \n                    https:\/\/www.populationpyramid.net\/jordan\/2017\/\n                    \n                  . Accessed 3 Dec. 2017."},{"key":"4079_CR22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.breast.2016.05.012","volume":"28","author":"R Glassey","year":"2016","unstructured":"Glassey R, Ives A, Saunders C, Musiello T. Decision making, psychological wellbeing and psychosocial outcomes for high risk women who choose to undergo bilateral prophylactic mastectomy - a review of the literature. Breast. 2016;28:130\u20135.","journal-title":"Breast"},{"key":"4079_CR23","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1200\/JCO.2015.63.0996","volume":"33","author":"ME Robson","year":"2015","unstructured":"Robson ME, Bradbury AR, Arun B, Domchek SM, Ford JM, Hampel HL, et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2015;33:3660\u20137.","journal-title":"J Clin Oncol"},{"key":"4079_CR24","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1245\/s10434-013-3205-1","volume":"20","author":"R Greenup","year":"2013","unstructured":"Greenup R, Buchanan A, Lorizio W, Rhoads K, Chan S, Leedom T, et al. Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort. Ann Surg Oncol. 2013;20:3254\u20138.","journal-title":"Ann Surg Oncol"},{"key":"4079_CR25","unstructured":"Breast Cancer Information Core: An open access on-line breast cancer mutation data base. Available at \n                    http:\/\/research.nhgri.nih.gov\/bic\/\n                    \n                  . Accessed 2 Dec. 2017."},{"issue":"5","key":"4079_CR26","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/ijc.30143","volume":"139","author":"R Bu","year":"2016","unstructured":"Bu R, Siraj AK, Al-Obaisi KA, Beg S, Al Hazmi M, Ajarim D, et al. Identification of novel BRCA founder mutations in middle eastern breast cancer patients using capture and sanger sequencing analysis. Int J Cancer. 2016;139(5):1091\u20137.","journal-title":"Int J Cancer"},{"issue":"2","key":"4079_CR27","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11033-011-0829-8","volume":"39","author":"W Mahfoudh","year":"2012","unstructured":"Mahfoudh W, Bouaouina N, Ahmed SB, Gabbouj S, Shan J, Mathew R, et al. Hereditary breast cancer in middle eastern and north African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population. Mol Biol Rep. 2012;39(2):1037\u201346.","journal-title":"Mol Biol Rep"},{"key":"4079_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-7-14","volume":"7","author":"L Kadouri","year":"2007","unstructured":"Kadouri L, Bercovich D, Elimelech A, Lerer I, Sagi M, Glusman G, et al. A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer. BMC Cancer. 2007;7:14. \n                    https:\/\/doi.org\/10.1186\/1471-2407-7-14\n                    \n                  .","journal-title":"BMC Cancer"},{"issue":"4","key":"4079_CR29","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/ijc.30771","volume":"141","author":"S Lolas Hamameh","year":"2017","unstructured":"Lolas Hamameh S, Renbaum P, Kamal L, Dweik D, Salahat M, Jaraysa T, et al. Genomic analysis of inherited breast cancer among Palestinian women: genetic heterogeneity and a founder mutation in TP53. Int J Cancer. 2017;141(4):750\u20136.","journal-title":"Int J Cancer"},{"issue":"10","key":"4079_CR30","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/sj.ejhg.5200717","volume":"9","author":"RB Barkardottir","year":"2001","unstructured":"Barkardottir RB, Sarantaus L, Arason A, Vehmanen P, Bendahl PO, Kainu T, et al. Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families. Eur J Hum Genet. 2001;9(10):773\u20139.","journal-title":"Eur J Hum Genet"},{"key":"4079_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10549-012-2021-9","volume":"134","author":"F Fostira","year":"2012","unstructured":"Fostira F, Tsitlaidou M, Papadimitriou C, Pertesi M, Timotheadou E, Stavropoulou AV, et al. Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic cooperative oncology group study. Breast Cancer Res Treat. 2012;134:353\u201362.","journal-title":"Breast Cancer Res Treat"},{"key":"4079_CR32","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1002\/cncr.29572","volume":"121","author":"RA Sanford","year":"2015","unstructured":"Sanford RA, Song J, Gutierrez-Barrera AM, Profato J, Woodson A, Litton JK, et al. High incidence of germline BRCA mutation in patients with ER low-positive\/PR low-positive\/HER-2 neu negative tumors. Cancer. 2015;121:3422\u20137.","journal-title":"Cancer"},{"key":"4079_CR33","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/1078-0432.CCR-10-2560","volume":"17","author":"AM Gonzalez-Angulo","year":"2011","unstructured":"Gonzalez-Angulo AM, Timms KM, Liu S, Chen H, Litton JK, Potter J, et al. Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Clin Cancer Res. 2011;17:1082\u20139.","journal-title":"Clin Cancer Res"},{"key":"4079_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0004.2010.01402.x","volume":"78","author":"SA Narod","year":"2010","unstructured":"Narod SA. Testing For CHEK2 in the cancer genetics clinic: ready for prime time? Clin Genet. 2010;78:1\u20137.","journal-title":"Clin Genet"},{"key":"4079_CR35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylk\u00e4s K, Roberts J, et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371:497\u2013506.","journal-title":"N Engl J Med"},{"key":"4079_CR36","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","volume":"34","author":"N Tung","year":"2016","unstructured":"Tung N, Lin NU, Kidd J, Allen BA, Singh N, Wenstrup RJ, et al. Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol. 2016;34:1460\u20138.","journal-title":"J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4079-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T19:12:56Z","timestamp":1549393976000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4079-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4079"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4079-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,6]]},"assertion":[{"value":"3 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of the King Hussein Cancer Center, Amman, Jordan. IRB approval number 11KHCC63. All patients provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"152"}}